Core Insights - Universal Technical Institute, Inc. emphasizes the importance of skilled collar and healthcare workers in the American economy, highlighting an urgent shortage of qualified workers despite high job availability [1][2] - The company aims to educate approximately 32,000 students in Fiscal Year 2026 through its divisions, UTI and Concorde Career Colleges, which focus on various in-demand fields [1][4] - The ongoing shift in workforce dynamics, influenced by reconsideration of traditional college paths and the impact of artificial intelligence, positions skilled collar and healthcare roles as stable employment options [4] Company Overview - Universal Technical Institute, Inc. is a leading workforce solutions provider founded in 1965, operating two main divisions: UTI and Concorde Career Colleges [5] - UTI operates 15 campuses across nine states, offering training in transportation, skilled trades, electrical, and energy sectors, while Concorde has 18 campuses in eight states and online, focusing on allied health, dental, nursing, and patient care programs [5]

Concorde-Phoenix to offer healthcare programs, including nursing, dental assistant/dental hygiene, medical and physical therapy assistant and allied health.PHOENIX, Jan. 27, 2026 /PRNewswire/ -- Universal Technical Institute, Inc., a national leader in workforce training programs, continues to advance its successful North Star strategy to address America's skilled labor shortage. Today, the company announced Phoenix as the site of a new facility for its healthcare division, Concorde Career Colleges. Cont ...

Core Insights - Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has presented cautious expectations for 2026, indicating significant internal changes are planned [2] - The company revised its 2025 organic revenue growth forecast down to 4.00% from 4.50% due to weaker demand in Latin America and emerging European markets, although overall revenue growth estimates remained stable due to favorable currency impacts [2] - Management cited last-minute cancellations of distributor orders from the Middle East and Eastern Europe as a key factor affecting performance [2] Company Ratings and Price Targets - Bernstein raised its price target for Zimmer Biomet Holdings from $97.00 to $99.00 while maintaining a 'Market Perform' rating, noting improving clarity in macro and policy uncertainties for U.S. healthcare stocks [2] - JPMorgan maintained a 'Neutral' rating on the company with a $100 price target, viewing 2026 as a pivotal year with growth opportunities while fundamentals remain strong [2] Business Focus - Zimmer Biomet Holdings, Inc. specializes in designing, manufacturing, and marketing orthopedic, spine, dental, and surgical products globally [2]

Core Insights - Universal Technical Institute (UTI) provides practical safety tips for families during the holiday season, focusing on safe driving, home heating, and holiday decorations [1][3]. Group 1: Holiday Safety Tips - UTI faculty members emphasize the importance of inspecting holiday lights and decorations to prevent fire and electrical hazards [2]. - Recommendations include using only outdoor-rated lights, plugging them into GFCI outlets, and using timers to avoid leaving lights unattended [4]. - Families are advised to keep fire extinguishers accessible and ensure smoke detectors are functional throughout the home [4]. Group 2: Heating System Maintenance - UTI instructors suggest checking heating systems, including furnaces and ventilation, to avoid costly repairs and maintain comfort during winter [2]. - Specific actions include inspecting ductwork for leaks and sealing gaps to improve heating efficiency [4]. Group 3: Safe Driving Practices - UTI highlights the need for vehicle preparation before holiday travel to prevent breakdowns and ensure passenger safety [3]. - Key recommendations include checking battery performance, maintaining proper tire pressure, and keeping fuel tanks at least half-full to prevent freezing [4]. Group 4: Company Overview - Universal Technical Institute, founded in 1965, is a leading provider of workforce solutions, offering education and support services for in-demand careers [3]. - UTI operates 15 campuses across nine states, providing training in transportation, skilled trades, and electrical programs [3].

Core Viewpoint - Universal Technical Institute, Inc. is advocating for the passage of the Veterans Education and Technology Skills (VETS) Opportunity Act to modernize the GI Bill, enabling veterans to utilize their benefits for accredited hybrid and flexible certificate and diploma programs [1][2]. Group 1: Company Initiatives - Universal Technical Institute has a history of supporting veterans in their transition to civilian life, educating over 3,300 veterans and military-affiliated students through various programs and scholarships [3]. - The company collaborates with the Department of Defense's SkillBridge program, offering on-base programs for service members and their families at multiple military installations [4]. - Universal Technical Institute partners with organizations like the USO and the U.S. Chamber of Commerce's Hiring Our Heroes initiative to provide transition workshops and career coaching [4]. Group 2: Industry Context - The skilled trades and healthcare sectors are experiencing significant demand, with strong wages and persistent shortages, making them ideal career paths for veterans [2][5]. - The company emphasizes the importance of a strong technical workforce for maintaining America's competitiveness in manufacturing and is committed to addressing the skilled labor shortage [5].

11/18/2025 1 Making the Invisible Visible Q4 FY25 Earnings Presentation November 18, 2025 While forward-looking statements are based on assumptions and analyses made by management of Varex that it believes to be reasonable under the circumstances, whether actual results and developments will meet such expectations depends on a number of risks and uncertainties which could cause actual results, performance, and financial condition to differ materially from such expectations. Such risks and uncertainties incl ...

Core Insights - Elevance Health, Inc. is a prominent healthcare company with a market capitalization of $71.7 billion, serving approximately 46.8 million members through various health plans and services [1] Financial Performance - The company is set to announce its fiscal Q3 earnings for 2025 on October 21st, with analysts projecting a profit of $5.01 per share, representing a 40.1% decline from $8.37 per share in the same quarter last year [2] - For the current year, analysts expect Elevance Health to report an EPS of $29.89, down 9.5% from $33.04 in fiscal 2024, but anticipate a rebound in FY2026 with a projected EPS of $30.96, reflecting a 3.6% year-over-year increase [3] Stock Performance - Shares of Elevance Health have decreased by 38.8% over the past 52 weeks, significantly underperforming compared to the S&P 500 Index, which has increased by 15.6%, and the Health Care Select Sector SPDR Fund, which has seen an 11.5% loss during the same period [4] Market Sentiment - Wall Street analysts maintain a "Moderate Buy" rating for Elevance Health, with 13 out of 21 analysts recommending "Strong Buy," one suggesting "Moderate Buy," six indicating "Hold," and one advising "Strong Sell." The mean price target for the stock is $359.06, suggesting a potential upside of 12.7% from current levels [6] Regulatory Environment - On September 25, shares of Elevance Health fell by 3% following the U.S. Commerce Department's initiation of a national security investigation into medical equipment imports, which could lead to new tariffs and create uncertainty within the healthcare sector [5]

Company Overview - Humana Inc. is one of the largest health care plan providers in the United States, founded in 1964 and headquartered in Louisville, KY [11] - The company offers health insurance benefits through various plans including Health Maintenance Organization (HMO), Private Fee-For-Service (PFFS), and Preferred Provider Organization (PPO) plans, along with specialty products like dental and vision benefits [11] Investment Analysis - Humana has a Zacks Rank of 3 (Hold) and a VGM Score of B, indicating a moderate investment outlook [12] - The company has a Momentum Style Score of B, with shares increasing by 29.9% over the past four weeks, suggesting positive price momentum [12] - For fiscal 2025, 11 analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate rising by $0.62 to $16.99 per share [12] - Humana has an average earnings surprise of +9.6%, indicating a history of exceeding earnings expectations [12] Conclusion - With a solid Zacks Rank and strong Momentum and VGM Style Scores, Humana is positioned as a noteworthy option for investors [13]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores are designed to help investors identify stocks with the highest potential to outperform the market in the short term [2] Zacks Style Scores Overview - The Style Scores categorize stocks into four main types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score emphasizes finding undervalued stocks based on financial ratios [3] - Growth Score focuses on a company's financial health and future growth potential [4] - Momentum Score capitalizes on existing trends in stock prices and earnings [5] - VGM Score combines the strengths of all three Style Scores to identify the most attractive investment opportunities [6] Zacks Rank and Performance - The Zacks Rank is a proprietary model that uses earnings estimate revisions to assist in stock selection [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +23.75% since 1988, significantly outperforming the S&P 500 [8] - Investors are encouraged to select stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for optimal returns [9] Stock Example: Humana Inc. (HUM) - Humana Inc. is a major health care plan provider in the U.S., offering various health insurance products [11] - Currently rated 3 (Hold) by Zacks, Humana has a VGM Score of A and a Value Style Score of A, indicating strong valuation metrics [12] - Recent analyst revisions have increased Humana's earnings estimate for fiscal 2025, with a consensus estimate of $16.93 per share and an average earnings surprise of +9.6% [12] - Given its solid Zacks Rank and favorable Style Scores, Humana is recommended for investors' consideration [13]